CKD Progression: interpreting guidelines through the lens of recent data; CKD and RAASi optimisation

Published 2023-02-17
Supported by an unrestricted educational grant by AstraZeneca

Speaker
Philip Kalra, United Kingdom

Panellist
Sunil Bhandari, United Kingdom

Moderator
Smeeta Sinha, United Kingdom

All Comments (3)